Preventive effect of acetyl-L-carnitine on the thermal hypoalgesia in streptozotocin-induced diabetic mice

European Journal of Pharmacology

Volumn 588, Issue 2-3, 2008, Pages 213-216

  Ohsawa, Masahiro ^a   Miyata, Shigeo ^a   Carlsson, Anna ^b   Kamei, Junzo ^a  

^a HOSHI UNIVERSITY   (Japan)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

(Mouse); Acetyl L carnitine; Diabetes; Hypoalgesia; Neuropathy(Mouse)">

Indexed keywords

ACETYLCARNITINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOSE RESPONSE; DRUG EFFECT; HYPOALGESIA; LATENT PERIOD; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; TAIL FLICK TEST; TEMPERATURE SENSE; TREATMENT DURATION; TREATMENT OUTCOME;

ACETYLCARNITINE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; MALE; MICE; MICE, INBRED ICR; PAIN THRESHOLD; REACTION TIME; STREPTOZOCIN;

EID: 44649133859     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.04.029     Document Type: Article

References (31)

1. Anand P., Terenghi G., Warner G., Kopelman P., Williams-Chestnut R.E., and Sinicropi D.V. The role of endogenous nerve growth factor in human diabetic neuropathy. Nat. Med. 2 (1996) 703-707
2. Calcutt N.A. Potential mechanisms of neuropathic pain in diabetes. Int. Rev. Neurobiol. 50 (2002) 205-228
3. Calcutt N.A., Allendoerfer K.L., Mizisin A.P., Middlemas A., Freshwater J.D., Burgers M., Ranciato R., Delcroix J.D., Taylor F.R., Shapiro R., Strauch K., Dudek H., Engber T.M., Galdes A., Rubin L.L., and Tomlinson D.R. Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy. J. Clin. Invest. 111 (2003) 507-514
4. Calcutt N.A., Freshwater J.D., and Mizisin A.P. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor. Diabetologia 47 (2004) 718-724
5. Cameron N.E., Cotter M.A., Basso M., and Hohman T.C. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 40 (1997) 271-281
6. Cameron N.E., Jack A.M., and Cotter M.A. Effect of alpha-lipoic acid on vascular responses and nociception in diabetic rats. Free Radic. Biol. Med. 31 (2001) 125-135
7. Cheng C., and Zochodne D.W. Sensory neurons with activated caspase-3 survive long-term experimental diabetes. Diabetes 52 (2003) 2363-2371
8. Chiechio S., Caricasole A., Barletta E., Storto M., Catania M.V., Copani A., Vertechy M., Nicolai R., Calvani M., Melchiorri D., and Nicoletti F. L-acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors. Mol. Pharmacol. 61 (2002) 989-996
9. Christianson J.A., Riekhof J.T., and Wright D.E. Beneficial effects of neurotrophin treatment on diabetes-induced cutaneous axon loss in mice. Exp. Neurol. 179 (2003) 188-199
10. Drel V.R., Mashtalir N., Ilnytska O., Shin J., Li F., Lyzogubov V.V., and Obrosova I.G. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity. Diabetes 55 (2006) 3335-3343
11. Dyck P.J., Dyck P.J., Larson T.S., O'Brien P.C., and Velosa J.A. Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group. Diabetes Care 23 (2000) 510-517
12. Fernandez E., Pallini R., Gangitano C., Del Fa.A., Sangiacomo C.O., Sbriccoli A., Ricoy J.R., and Rossi G.F. Effects of L-carnitine, L-acetylcarnitine and gangliosides on the regeneration of the transected sciatic nerve in rats. Neurol. Res. 11 (1989) 5-62
13. Flatters S.J., Xiao W.H., and Bennett G.J. Acetyl-L-carnitine prevents and reduces paclitaxel-induced painful peripheral neuropathy. Neurosci. Lett. 397 (2006) 219-223
14. Hart A.M., Wiberg M., Youle M., and Terenghi G. Systemic acetyl-L-carnitine eliminates sensory neuronal loss after peripheral axotomy: a new clinical approach in the management of peripheral nerve trauma. Exp. Brain Res. 145 (2002) 182-189
15. Hart A.M., Wilson A.D., Montovani C., Smith C., Johnson M., Terenghi G., and Youle M. Acetyl-L-carnitine: a pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathy. AIDS 18 (2004) 1549-1560
16. Hosein E.A., and Orzeck A. Some physiological and biochemical properties of acetyl-L-carnitine isolated from brain tissue extracts. Int. J. Neuropharmacol. 3 (1964) 71-76
17. Hotta N., Akanuma Y., Kawamori R., Matsuoka K., Oka Y., Shichiri M., Toyota T., Nakashima M., Yoshimura I., Sakamoto N., Shigeta, and the ADCT Study Group. Long-term clinical effects of epalrestat, an aldose reductase inhibitor on diabetic peripheral neuropathy. The 3-year, multicenter, comparative aldose reductase inhibitor-diabetes complication trial. Diabetes Care 29 (2006) 1538-1544
18. Ido Y., McHowat J., Chang K.C., Arrigoni-Martelli E., Orfalian Z., Kilo C., Corr P.B., and Williamson J.R. Neural dysfunction and metabolic imbalances in diabetic rats: prevention by acetyl-L-carnitine. Diabetes 43 (1994) 1469-1477
19. Lowitt S., Malone J.I., Salem A.F., Korthals J., and Benford S. Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes. Metabolism 44 (1995) 677-680
20. Nakae M., Kamiya H., Naruse K., Horio N., Ito Y., Mizubayashi R., Hamada Y., Nakashima E., Akiyama N., Kobayashi Y., Watarai A., Kimura N., Horiguchi M., Tabata Y., Oiso Y., and Nakamura J. Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats. Diabetes 55 (2006) 1470-1477
21. Nakamura J., Kato K., Hamada Y., Nakayama M., Chaya S., Nakashima E., Naruse K., Kasuya Y., Mizubayashi R., Miwa K., Yasuda Y., Kamiya H., Ienaga K., Sakakibara F., Koh N., and Hotta N. A protein kinase C-β-selective inhibitor ameliorates neural dysfunction in streptozotocin-induced diabetic rats. Diabetes 48 (1999) 2090-2095
22. Obrosova I.G., Van Huysen C., Fathallah L., Cao X., Stevens M.J., and Greene D.A. Evaluation of alpha(1)-adrenoceptor antagonist on diabetes-induced changes changes in peripheral nerve function, metabolism, and antioxidative defense. FASEB J. 14 (2000) 1548-1558
23. Ohsawa M., and Kamei J. Possible involvement of spinal protein kinase C in thermal allodynia and hyperalgesia in diabetic mice. Eur. J. Pharmacol. 372 (1999) 221-228
24. Pisano C., Pratesi G., Laccabue D., Zunino F., Lo Giudice P., Bellucci A., Pacifici L., Camerini B., Vesci L., Castorina M., Cicuzza S., Tredici G., Marmiroli P., Nicolini G., Galbiati S., Calvani M., Carminati P., and Cavaletti G. Paclitaxel and cisplatin-induced neurotoxicity: a protective role of acetyl-l-carnitine. Clin. Cancer Res. 9 (2003) 5756-5767
25. Quatraro A., Roca P., Donzella C., Acampora R., Marfella R., and Giugliano D. Acetyl-L-carntine for symptomatic diabetic neuropathy. Diabetologia 38 (1995) 123
26. Sima A.A., Ristic H., Merry A., Kamijo M., Lattimer S.A., Stevens M.J., and Greene D.A. The primay preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat. J. Clin. Invest. 97 (1996) 1900-1907
27. Sima A.A., Calvani M., Mehra M., and Amato A. Acetyl-L-Carnitine Study Group. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care 28 (2005) 89-94
28. Stevens M.J., Lattimer S.A., Feldman E.L., Helton E., Millington D.S., Sima A.A.F., and Greene D.A. Acetyl-L-carnitine deficiency as a cause of altered nerve myo-inositol content, Na+/K+-ATPase activity and motor conduction velocity in the streptozotocine diabetic rat. Metabolism 45 (1996) 865-872
29. Stevens M.J., Li F., Drel V.R., Abatan O.I., Kim H., Burnett D., Larkin D., and Obrosova I.G. Nicotinamide reverses neurological and neurovascular deficits in streptozotocin diabetic rats. J. Pharmacol. Exp. Ther. 320 (2007) 458-464
30. Vinik A.I., Park T.S., Stansberry K.B., and Pittenger G.L. Diabetic neuropathies. Diabetologia 43 (2000) 957-973
31. Wilson A.D., Hart A., Brannstrom T., Wiberg M., and Terenghi G. Primary sensory neuronal rescue with systemic acetyl-L-carnitine following peripheral axotomy. A dose-response analysis. Br. J. Blast. Surg. 56 (2003) 732-739